miR-话题@MedSci

#miR#

540篇内容 | 2666人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1930870, encodeId=5b6e19308e0c4, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, objectTitle=Miracor Medical 宣布 PiCSO® 获得 FDA 试验用器械豁免许可, objectType=article, longId=736789, objectId=ee89e36789b7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ee89e36789b7, replyNumber=0, likeNumber=101, createdTime=2023-01-23, rootId=0, userName=smallant2002, userId=0a27288, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ee89e36789b7, moduleTitle=Miracor Medical 宣布 PiCSO® 获得 FDA 试验用器械豁免许可, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ee89e36789b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1930869, encodeId=bee219308693d, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, objectTitle=著名癌症生物学家、miRNA研究领军人物因实验室学术不端被处罚, objectType=article, longId=733029, objectId=89d6e33029a2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=89d6e33029a2, replyNumber=0, likeNumber=115, createdTime=2023-04-02, rootId=0, userName=smallant2002, userId=0a27288, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=89d6e33029a2, moduleTitle=著名癌症生物学家、miRNA研究领军人物因实验室学术不端被处罚, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=89d6e33029a2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1930857, encodeId=65f6193085e3d, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, objectTitle=Diabetes：单核细胞miRNA与2型糖尿病的关系, objectType=article, longId=294915, objectId=22de294915b3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=22de294915b3, replyNumber=0, likeNumber=90, createdTime=2022-12-01, rootId=0, userName=smallant2002, userId=0a27288, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=22de294915b3, moduleTitle=Diabetes：单核细胞miRNA与2型糖尿病的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=22de294915b3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1930865, encodeId=bf00193086513, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, objectTitle=Sci Adv：方向前/王秀梅开发水凝胶递送miRNA策略，通过抗衰老治疗骨关节炎, objectType=article, longId=724062, objectId=395ee24062ca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=395ee24062ca, replyNumber=0, likeNumber=119, createdTime=2022-08-11, rootId=0, userName=smallant2002, userId=0a27288, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=395ee24062ca, moduleTitle=Sci Adv：方向前/王秀梅开发水凝胶递送miRNA策略，通过抗衰老治疗骨关节炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=395ee24062ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1930858, encodeId=c9dd19308585c, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, objectTitle=辉瑞/BioNTech旗下COVID-19疫苗Comirnaty：推迟决定是否让5岁以下幼童接种Comirnaty, objectType=article, longId=295529, objectId=9c5d2955294a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9c5d2955294a, replyNumber=0, likeNumber=89, createdTime=2022-12-26, rootId=0, userName=smallant2002, userId=0a27288, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9c5d2955294a, moduleTitle=辉瑞/BioNTech旗下COVID-19疫苗Comirnaty：推迟决定是否让5岁以下幼童接种Comirnaty, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9c5d2955294a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1930853, encodeId=b416193085390, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, objectTitle=A&R: 雌激素诱导的hsa-miR-10b-5p在系统性红斑狼疮患者的T细胞中升高，并下调富含丝氨酸/精氨酸的剪接因子1, objectType=article, longId=221671, objectId=f8602216e184, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f8602216e184, replyNumber=0, likeNumber=111, createdTime=2022-09-01, rootId=0, userName=smallant2002, userId=0a27288, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f8602216e184, moduleTitle=A&R: 雌激素诱导的hsa-miR-10b-5p在系统性红斑狼疮患者的T细胞中升高，并下调富含丝氨酸/精氨酸的剪接因子1, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f8602216e184)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1930861, encodeId=45b71930861c8, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, objectTitle=Cardiovasc Diabetol：miR-21/ROS/HNE水平降低与习惯干预后的低血糖有关, objectType=article, longId=301113, objectId=b6103011132e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b6103011132e, replyNumber=0, likeNumber=112, createdTime=2022-08-05, rootId=0, userName=smallant2002, userId=0a27288, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b6103011132e, moduleTitle=Cardiovasc Diabetol：miR-21/ROS/HNE水平降低与习惯干预后的低血糖有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b6103011132e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1930871, encodeId=184e19308e1cb, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, objectTitle=Aging Cell: 肿瘤抑制因子miR-34c作为AD治疗新靶点, objectType=article, longId=291599, objectId=dd7429159939, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dd7429159939, replyNumber=0, likeNumber=102, createdTime=2022-08-03, rootId=0, userName=smallant2002, userId=0a27288, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dd7429159939, moduleTitle=Aging Cell: 肿瘤抑制因子miR-34c作为AD治疗新靶点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dd7429159939)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1930866, encodeId=19f219308668e, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, objectTitle=长效C5补体抑制剂Ultomiris治疗视神经脊髓炎的III期试验取得积极结果, objectType=article, longId=726365, objectId=c0f8e2636523, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c0f8e2636523, replyNumber=0, likeNumber=101, createdTime=2022-08-11, rootId=0, userName=smallant2002, userId=0a27288, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c0f8e2636523, moduleTitle=长效C5补体抑制剂Ultomiris治疗视神经脊髓炎的III期试验取得积极结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c0f8e2636523)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1930839, encodeId=17da1930839e5, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, objectTitle=JAHA：循环miR-19b-3p作为急性心衰患者新型预后生物标志物, objectType=article, longId=218207, objectId=651a21820ea2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=651a21820ea2, replyNumber=0, likeNumber=105, createdTime=2022-03-02, rootId=0, userName=smallant2002, userId=0a27288, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=651a21820ea2, moduleTitle=JAHA：循环miR-19b-3p作为急性心衰患者新型预后生物标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=651a21820ea2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1930845, encodeId=5c081930845b2, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, objectTitle=FDA批准在5至11岁儿童中紧急使用Comirnaty, objectType=article, longId=219578, objectId=81fb2195e841, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=81fb2195e841, replyNumber=0, likeNumber=94, createdTime=2022-09-12, rootId=0, userName=smallant2002, userId=0a27288, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=81fb2195e841, moduleTitle=FDA批准在5至11岁儿童中紧急使用Comirnaty, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=81fb2195e841)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1930847, encodeId=640b193084e6a, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, objectTitle=Emodin inhibits TGF-β2 by activating the FOXD3/miR-199a axis in ovarian cancer cells in vitro, objectType=article, longId=220876, objectId=84142208e66f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=84142208e66f, replyNumber=0, likeNumber=90, createdTime=2022-10-16, rootId=0, userName=smallant2002, userId=0a27288, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=84142208e66f, moduleTitle=Emodin inhibits TGF-β2 by activating the FOXD3/miR-199a axis in ovarian cancer cells in vitro, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=84142208e66f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1930863, encodeId=3dfe19308638e, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, objectTitle=Alvotech和STADA与艾伯维解决欧洲专利纠纷，为Humira®的无柠檬酸盐、高浓度生物仿制药HUKYNDRA®(AVT02)上市铺平道路, objectType=article, longId=723787, objectId=0b3be23787cf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0b3be23787cf, replyNumber=0, likeNumber=109, createdTime=2023-03-22, rootId=0, userName=smallant2002, userId=0a27288, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0b3be23787cf, moduleTitle=Alvotech和STADA与艾伯维解决欧洲专利纠纷，为Humira®的无柠檬酸盐、高浓度生物仿制药HUKYNDRA®(AVT02)上市铺平道路, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0b3be23787cf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1930867, encodeId=49c7193086eee, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, objectTitle=Cardiovasc Diabetol：习惯干预后miR-21/ROS/HNE水平降低与血糖降低相关, objectType=article, longId=727603, objectId=87c2e2760399, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=87c2e2760399, replyNumber=0, likeNumber=79, createdTime=2022-06-09, rootId=0, userName=smallant2002, userId=0a27288, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=87c2e2760399, moduleTitle=Cardiovasc Diabetol：习惯干预后miR-21/ROS/HNE水平降低与血糖降低相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=87c2e2760399)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1930846, encodeId=3e1c193084664, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, objectTitle=埃克替尼与安罗替尼治疗晚期非小细胞肺癌疗效比较及对miR-185-5p、miR-204-5p表达水平影响观察, objectType=article, longId=220671, objectId=e6e52206e1f8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e6e52206e1f8, replyNumber=0, likeNumber=101, createdTime=2022-04-17, rootId=0, userName=smallant2002, userId=0a27288, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e6e52206e1f8, moduleTitle=埃克替尼与安罗替尼治疗晚期非小细胞肺癌疗效比较及对miR-185-5p、miR-204-5p表达水平影响观察, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e6e52206e1f8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1930852, encodeId=c39b1930852b0, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, objectTitle=BP：构建环状RNA- miRNA- mRNA网络揭示补阳还五汤治疗脑缺血的潜在机制, objectType=article, longId=221399, objectId=0f1322139987, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0f1322139987, replyNumber=0, likeNumber=102, createdTime=2022-01-02, rootId=0, userName=smallant2002, userId=0a27288, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0f1322139987, moduleTitle=BP：构建环状RNA- miRNA- mRNA网络揭示补阳还五汤治疗脑缺血的潜在机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0f1322139987)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1930851, encodeId=fbb3193085183, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, objectTitle=Long non-coding RNA NORAD promotes cell proliferation and glycolysis in non-small cell lung cancer by acting as a sponge for miR-136-5p, objectType=article, longId=221116, objectId=2a872211164b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2a872211164b, replyNumber=0, likeNumber=99, createdTime=2022-03-22, rootId=0, userName=smallant2002, userId=0a27288, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2a872211164b, moduleTitle=Long non-coding RNA NORAD promotes cell proliferation and glycolysis in non-small cell lung cancer by acting as a sponge for miR-136-5p, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2a872211164b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1930834, encodeId=60dc193083425, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, objectTitle=Urol Int：miR-155-5p通过靶向PEG3促进透明细胞肾细胞癌的细胞增殖和迁移, objectType=article, longId=214394, objectId=d7d421439443, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d7d421439443, replyNumber=0, likeNumber=104, createdTime=2021-12-25, rootId=0, userName=smallant2002, userId=0a27288, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d7d421439443, moduleTitle=Urol Int：miR-155-5p通过靶向PEG3促进透明细胞肾细胞癌的细胞增殖和迁移, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d7d421439443)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1930868, encodeId=1d75193086803, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, objectTitle=核酸治疗: miR-23b-3p是一个有希望的阿尔茨海默病治疗靶点, objectType=article, longId=728334, objectId=72bfe283342c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=72bfe283342c, replyNumber=0, likeNumber=104, createdTime=2022-11-16, rootId=0, userName=smallant2002, userId=0a27288, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=72bfe283342c, moduleTitle=核酸治疗: miR-23b-3p是一个有希望的阿尔茨海默病治疗靶点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=72bfe283342c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1930859, encodeId=5681193085926, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, objectTitle=JMIR：开发机器学习模型来预测严重的慢性阻塞性肺疾病恶化, objectType=article, longId=299882, objectId=296829988277, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=296829988277, replyNumber=0, likeNumber=0, createdTime=2022-06-30, rootId=0, userName=smallant2002, userId=0a27288, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=296829988277, moduleTitle=JMIR：开发机器学习模型来预测严重的慢性阻塞性肺疾病恶化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=296829988277)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

miR

2020-05-29

smallant2002 (审核中...)

前往app查看评论内容

#miR#

Miracor Medical 宣布 PiCSO® 获得 FDA 试验用器械豁免许可

2023-01-23

smallant2002 (审核中...)

前往app查看评论内容

#miR#

著名癌症生物学家、miRNA研究领军人物因实验室学术不端被处罚

2023-04-02

smallant2002 (审核中...)

前往app查看评论内容

#miR#

Diabetes：单核细胞miRNA与2型糖尿病的关系

2022-12-01

smallant2002 (审核中...)

前往app查看评论内容

#miR#

Sci Adv：方向前/王秀梅开发水凝胶递送miRNA策略，通过抗衰老治疗骨关节炎

2022-08-11

smallant2002 (审核中...)

前往app查看评论内容

#miR#

辉瑞/BioNTech旗下COVID-19疫苗Comirnaty：推迟决定是否让5岁以下幼童接种Comirnaty

2022-12-26

smallant2002 (审核中...)

前往app查看评论内容

#miR#

A&R: 雌激素诱导的hsa-miR-10b-5p在系统性红斑狼疮患者的T细胞中升高，并下调富含丝氨酸/精氨酸的剪接因子1

2022-09-01

smallant2002 (审核中...)

前往app查看评论内容

#miR#

Cardiovasc Diabetol：miR-21/ROS/HNE水平降低与习惯干预后的低血糖有关

2022-08-05

smallant2002 (审核中...)

前往app查看评论内容

#miR#

Aging Cell: 肿瘤抑制因子miR-34c作为AD治疗新靶点

2022-08-03

smallant2002 (审核中...)

前往app查看评论内容

#miR#

长效C5补体抑制剂Ultomiris治疗视神经脊髓炎的III期试验取得积极结果

2022-08-11

smallant2002 (审核中...)

前往app查看评论内容

#miR#

JAHA：循环miR-19b-3p作为急性心衰患者新型预后生物标志物

2022-03-02

smallant2002 (审核中...)

前往app查看评论内容

#miR#

FDA批准在5至11岁儿童中紧急使用Comirnaty

2022-09-12

smallant2002 (审核中...)

前往app查看评论内容

#miR#

Emodin inhibits TGF-β2 by activating the FOXD3/miR-199a axis in ovarian cancer cells in vitro

2022-10-16

smallant2002 (审核中...)

前往app查看评论内容

#miR#

Alvotech和STADA与艾伯维解决欧洲专利纠纷，为Humira®的无柠檬酸盐、高浓度生物仿制药HUKYNDRA®(AVT02)上市铺平道路

2023-03-22

smallant2002 (审核中...)

前往app查看评论内容

#miR#

Cardiovasc Diabetol：习惯干预后miR-21/ROS/HNE水平降低与血糖降低相关

2022-06-09

smallant2002 (审核中...)

前往app查看评论内容

#miR#

埃克替尼与安罗替尼治疗晚期非小细胞肺癌疗效比较及对miR-185-5p、miR-204-5p表达水平影响观察

2022-04-17

smallant2002 (审核中...)

前往app查看评论内容

#miR#

BP：构建环状RNA- miRNA- mRNA网络揭示补阳还五汤治疗脑缺血的潜在机制

2022-01-02

smallant2002 (审核中...)

前往app查看评论内容

#miR#

Long non-coding RNA NORAD promotes cell proliferation and glycolysis in non-small cell lung cancer by acting as a sponge for miR-136-5p

2022-03-22

smallant2002 (审核中...)

前往app查看评论内容

#miR#

Urol Int：miR-155-5p通过靶向PEG3促进透明细胞肾细胞癌的细胞增殖和迁移

2021-12-25

smallant2002 (审核中...)

前往app查看评论内容

#miR#

核酸治疗: miR-23b-3p是一个有希望的阿尔茨海默病治疗靶点

2022-11-16

smallant2002 (审核中...)

前往app查看评论内容

#miR#

JMIR：开发机器学习模型来预测严重的慢性阻塞性肺疾病恶化

2022-06-30

科室
- - 订阅+
  - 更多科室
工具
服务